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DObjective: Risk factors for mortality after neonatal cardiac surgery have been seldom studied. We sought to
identify contemporary risk factors for mortality and the impact of surgical technical performance on surgical
outcomes after neonatal cardiac surgery.
Methods: We conducted a matched case-control study comparing 56 neonates who died after cardiac surgery
(2002-2008) with 56 survivors matched by surgical procedure and year of surgery. Surgical efficacy for repair or
palliation was graded using a reliable simple surgical technical score. Patient and surgical characteristics were
compared for the survivors and nonsurvivors using paired analyses.
Results: There was no significant difference between patients who died and their matched controls in terms of
age, Aristotle score, Risk Adjustment in Congenital Heart Surgery-1 category, and single versus biventricular
repair. When compared with survivors, patients who died were more likely to be premature (41% vs 5%,
P<.001), to weigh less than 2.5 kg (25% vs 9%, P ¼ .05), and to have inadequate surgical repair or palliation
(55% vs 9%, P<.001). Cardiopulmonary bypass time was longer for the patients who died (median, 159 vs 133
minutes, P¼ .002). Highest postoperative lactate (median, 9.0 vs 6.0, P<.001), use of extracorporeal membrane
oxygenation (71% vs 13%, P<.001), and reoperation during the same admission (75% vs 2%, P<.001) were
also associated with death. In multivariable analysis, inadequate surgical repair or palliation (odds ratio, 11,
P ¼ .02) and need for postoperative extracorporeal membrane oxygenation (odds ratio, 5.1, P ¼ .009) were
the only risk factors associated with hospital death.
Conclusions: Our study highlights the need for optimal technical performance to minimize neonatal deaths.
This has important implications when sustaining or developing a pediatric cardiac program. (J Thorac Cardio-
vasc Surg 2012;144:1119-24)Earn CME credits at
http://cme.ctsnetjournals.org
Survival after neonatal cardiac surgery has been improving
since the concept of early complete repair or palliation was
introduced 20 years ago.1-3 Previous clinical research has
established the qualitative and quantitative causes of death
for all patients undergoing congenital heart surgery.
Implementation of early repair in the newborn, when
possible, is associated with the known benefits of attaining
effective physiologic or anatomic circulation. However,
both corrective and palliative neonatal cardiac surgerye Departments of Cardiovascular Surgerya and Cardiology,b Children’s Hos-
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The Journal of Thoracic and Carremain high-risk undertakings despite advances in neonatal
medicine, neonatal monitoring, and surgical management.
The exact mechanisms leading to death after neonatal
cardiac surgery are complex. However, the newborns under-
going cardiac surgery have limited physiologic reserves to
compensate for perioperative adverse events. In addition
to the newborn-related challenges of low birth weight, ana-
tomic diversity, cardiopulmonary bypass, and other organi-
zational and process factors can directly or indirectly
influence hospital outcome.
This study sought to identify specific variables, including
patient physiologic variables and technical outcomes of the
surgery that might be associated with death after neonatal
cardiac surgery. To accomplish this, we performed
a matched case-control study of survivors and nonsurvivors
undergoing neonatal cardiac surgery from Children’s Hos-
pital Boston.MATERIALS AND METHODS
Patients
The study was approved by the hospital institutional review board, and
informed consent was waived. Patients were identified using the computer-
ized database of the Departments of Cardiology and Cardiac Surgery at
Children’s Hospital Boston. Neonatal cardiac surgery was defined as any
primary surgical procedure performed on newborns aged 30 days or less.diovascular Surgery c Volume 144, Number 5 1119
Abbreviation and Acronym
ECMO ¼ extracorporeal membrane oxygenation
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DWe excluded patients who underwent heart transplantation, ligation of the
patent ductus only, or resection of cardiac tumor as their primary
procedure.
All these index neonatal cardiac surgeries were primary operations and
did not include reoperations or primary catheter-based interventions. Neo-
nates who survived congenital heart surgery (controls) and those who did
not survive (cases) were included in the study.
From January 2002 to December 2008, a total of 65 patient deaths after
neonatal cardiac surgery were identified. It is our programmatic policy to
aggressively pursue the diagnosis of residual or unexpected cardiac lesions
in postoperative patients unresponsive to medical therapy. As a result, early
invasive and noninvasive imaging and intervention are performed urgently
after neonatal cardiac surgery.
Technical Performance Score
A technical performance score previously developed by our division
was adopted to determine the extent of successful completion of various
mandatory surgical tasks associated with each specific surgical repair or
palliation.4,5 For each subprocedure, score categories were defined as
optimal, adequate, and inadequate. The parameters for score assessment
were based on clinical, echocardiographic, and cardiac catheterization
data and defined by consensus of physicians and surgeons at Children’s
Hospital Boston. Published technical assessment tools were available for
single ventricle palliation and 2 ventricle repair (eg, tetralogy of Fallot,
ventricular septal defect, transposition of great vessels).4,5 An overall
score also was defined, wherein the operation was graded as optimal if
all subprocedures were optimal; adequate if procedures were optimal or
adequate, but none inadequate; and inadequate if 1 or more
subprocedures was inadequate. For example, in case of tetralogy of
Fallot repair, this was subdivided into individual entities according to the
specific anatomic regions noted for repair: atrial and ventricular level,
right ventricular outflow tract, and pulmonary artery work. In the case of
ventricular septal defect entity, a small residual shunt 3 mm or less was
considered adequate but inadequate if greater than 3 mm or it required
a reintervention. In certain conditions (eg, unbalanced canal or
hypoplastic left heart syndrome), technical score calculation was
achieved by adopting subprocedures used previously in biventricular or
single ventricle palliation. For example, for the entity-distal arch recon-
struction, an adequate score was given if peak velocity was 3 m/s or less
by echocardiography, mild gradient was 20 mm Hg or less, or there was
successful intraoperative revision. An inadequate distal arch reconstruction
was defined as peak velocity greater than 3 m/s by echocardiography, more
than 20 mm Hg, need for reintervention during initial hospital stay, and
clinical evidence of coarctation.
Finding residual defects and calculating a score were based on various
imaging modalities available in most patients; however, some patients
could not be technically graded because of the severity of illness or lack
of information, and therefore were excluded.
Data Collection
Clinical data (echocardiograms, clinical evaluation, and catheteriza-
tion) were collected for assessment. Other variables included preoperative
patient characteristics (age and weight at operation, prematurity, noncar-
diac anomalies, anatomic subtype, and presence of restrictive atrial
septum), procedural characteristics (cardiopulmonary bypass times, circu-
latory arrest and regional cerebral perfusion times, aortic crossclamp
times), postoperative characteristics (reinterventions, highest postoperative1120 The Journal of Thoracic and Cardiovascular Surlactate), and use of extracorporeal membrane oxygenation (ECMO). Fur-
ther, we assigned the surgeon’s experience based on time as an attending
surgeon (<5 or 5 years).
Study Design
This was a retrospective, single-center study that used a matched case-
control design. For each nonsurvivor, we screened our database for pa-
tient(s) with a similar surgical procedure during the same year of surgery
who did not die. After generating a list of potential matches for each
case, we randomly selected 1 matched survivor for each nonsurvivor to
minimize selection bias.
Statistical Analysis
Patient and procedural characteristics were compared for the matched
survivors and nonsurvivors using the Wilcoxon signed-rank test for contin-
uous variables and McNemar’s test for dichotomous variables. Conditional
logistic regression was used for multivariable analysis. Variables with a P
value less than .1 in the bivariate analysis were considered for inclusion in
themodel, and aP value less than .05was set for retention in the final model.RESULTS
Study Population
Between January 2002 and December 2008, a total of 65
patient deaths after neonatal cardiac surgery meeting eligi-
bility criteria were identified. We excluded 9 nonsurvivors
because of lack of an appropriate control match (n¼ 4; ven-
tricular tumor resection, repair of total anomalous veins and
hypoplastic left heart syndrome, repair of severe truncal in-
sufficiency and interrupted arch) or data were incomplete to
assess technical efficacy (n¼ 5). The remaining 56 patients
who died in the hospital after neonatal cardiac surgery were
matched with 56 patients who survived neonatal cardiac
surgery. All patients had complete echocardiograms.
The cohort of cardiac diagnoses encompassed a full spec-
trum of common and uncommon congenital heart defects.
Table 1 summarizes the distribution of cardiac diagnoses
and extracardiac diagnoses among survivors and nonsurvi-
vors after neonatal heart surgery included in the study. Dur-
ing the same time period, our program performed 817
neonatal cardiac surgical repairs or palliations with an over-
all mortality of 7.7% excluding transplantation.Comparison of Survivors Versus Nonsurvivors
When survivors were compared with nonsurvivors with
respect to patient and surgical characteristics, there were
no statistically significant differences in terms of age, Aris-
totle scores, Risk Adjustment in Congenital Heart Surgery-1
risk category, surgeon’s experience, timing of surgery
(weekend vs weekday), or single versus biventricular repair
(Table 2). When compared with survivors, patients who died
were more likely to be premature (<37 weeks gestational
age) (41% vs 5%, P<.001) and to weigh less than 2.5 kg
(25% vs 9%, P ¼ .05). Inadequate surgical repair or palli-
ation (55% vs 9%, P<.001) was also associated with death.
Intraoperatively, there were no statistical differences in
aortic crossclamp time or circulatory arrest time betweengery c November 2012
TABLE 1. Distribution of cardiac diagnoses and extracardiac
diagnoses among survivors and nonsurvivors after congenital heart
surgery
No. of nonsurvivors
(n ¼ 56)
No. of survivors
(n ¼ 56)
HLHS
MA/AA 12 11
MS/AA 7 9
DORV 1 0
MS/AS 1 1
D-TGA/VSD 3 3
ASD/MR/PDA 1 1
DORV (subpulmonic VSD) 1 1
DORV (subaortic VSD) 1 1
Conoventricular VSD 2 2
VSD/coarctation 3 3
IAA/VSD 2 2
TA type II 4 4
TOF/PS 4 5
TOF/PA 2 3
TOF/coarctation 1 0
TOF/aortic stenosis 1 0
AVSD unbalanced 3 3
DILV 1 0
TA (type IIIB) 3 3
PA/IVS 3 4
Chromosome anomaly
T21 1 1
Deletion 4q32.3 1 0
Heterotaxy 1 0
PHACE syndrome 1 0
Corneilia–DeLange 1 0
Rubenstein–Taebi 1 0
Skeletal myopathy 1 0
Patients can have more than 1 diagnosis. HLHS, Hypoplastic left heart syndrome;
MA/AA, mitral atresia/aortic atresia; MS/AA, mitral stenosis/aortic aorta; DORV,
double-outlet right ventricle; MS/AS, mitral stenosis/aortic stenosis; D-TGA,
dextro-transposition of the great arteries; VSD, ventricular septal defect; ASD, atrial
septal defect; MR, mitral regurgitation; PDA, patent ductus arteriosus; IAA, interrup-
ted aortic arch; TA, truncus arteriosus; TOF, tetralogy of Fallot; PS, pulmonary steno-
sis; PA, pulmonary atresia; AVSD, atrioventricular septal defect; DILV, double-inlet
left ventricle; IVS, interventricular septum; T21, trisomy of chromosome 21; PHACE,
Posterior fossa abnormalities and other structural brain abnormalities; Hemangi-
oma(s) of the cervical facial region; Arterial cerebrovascular anomalies; Cardiac de-
fects, aortic coarctation, and other aortic abnormalities; Eye anomalies.
TABLE 2. Comparison of demographic and surgical characteristics
for matched neonatal cohorts
Nonsurvivor
(n ¼ 56)
Survivors
(n ¼ 56) P value
Weight (kg<2.5) 14 (25) 5 (9) .05
Premature 23 (41) 3 (5) <.001
Surgery on weekend 1 (2) 1 (2) 1.0
Type of ventricle repair .38
Single ventricle 34 (61) 36 (65)
Biventricular 22 (39) 19 (35)
RACHS-1 risk category 1.0
1 1 (2) 2 (4)
2 6 (11) 11 (20)
3 15 (27) 4 (7)
4 7 (13) 10 (18)
6 27 (48) 29 (52)
Surgeon experience .61
<5 y 16 (29) 13 (23)
5 y 40 (71) 43 (77)
Aristotle basic score 11.5 (6.0-14.5) 14.5 (6.0-14.5) .72
Aristotle complexity .98
2 14 (25) 14 (25)
3 7 (13) 6 (11)
4 35 (62) 36 (64)
Surgical efficacy <.001
Optimal 17 (30) 47 (84)
Adequate 8 (14) 4 (7)
Inadequate 31 (55) 5 (9)
RACHS-1, Risk Adjustment in Congenital Heart Surgery-1.
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Dsurvivors and nonsurvivors (Table 3). Cardiopulmonary by-
pass time was longer for the patients who died (median,
159 vs 133 minutes; P ¼ .002). For neonates who did not
die, thosewho had ECMOhad longer crossclamp times (me-
dian, 175 vs 130; P¼ .007). For thosewho did die, therewas
no difference in crossclamp time for those who had ECMO
versus those who did not (median, 158 with ECMO, 164
with no ECMO; P¼ .80). Highest postoperative lactate (me-
dian, 9.0 vs 6.0; P< .001), use of ECMO (71% vs 13%,
P < .001), and reoperation during the same admission
(75% vs 16%,P<.001) were strongly associated with death
(Table 4). The surgical indications for reoperations are shownThe Journal of Thoracic and Carin Table 5. For those with adequate outcome, 6 of 12 (50%)
underwent reoperation. For those who sustained an inade-
quate outcome, 92% underwent reoperation (P<.001).
On multivariable analysis of factors associated with neo-
natal cardiac surgical mortality, inadequate surgical repair
or palliation (odds ratio, 11; P ¼ .02) and use of ECMO
(odds ratio, 5.1; P ¼ .009) were the only 2 variables associ-
ated with hospital death after neonatal cardiac surgery.DISCUSSION
Many advances during the past decade in neonatal car-
diac surgery have resulted in a definite reduction in mortal-
ity and morbidity.6 For example, existing mortalities for
hypoplastic left heart syndrome undergoing stage I have de-
creased to less than 20% in most centers.7,8 Nonetheless,
neonatal cardiac surgery remains a high-risk undertaking
demanding consistent optimal technical repair or palliation,
as well as comprehensive intensive care support and surgi-
cal management. Definitive causes of death after cardiac
surgery have been attributed to a host of pathophysiologic
factors, conduct of surgery, adequacy of repair or palliation,
and postoperative management including the use of ECMO.
Until recently, the definition of optimal surgical perfor-
mance in congenital heart surgery was measured by hospital
mortality usually in the form of cumulative sum analysis.diovascular Surgery c Volume 144, Number 5 1121
TABLE 3. Comparison of intraoperative characteristics for matched
neonatal cohorts
Nonsurvivor
(n ¼ 56)
Survivors
(n ¼ 56)
P
value
CXT (n ¼ 49, 49) 76 (10-189) 67 (20-179) .21
CAT (n ¼ 16, 16) 43 (4-189) 34 (0-60) .61
CPB (n ¼ 48, 48) 159 (87-389) 133 (86-422) .002
CXT, Crossclamp time; CAT, circulatory arrest time; CPB, cardiopulmonary bypass
time.
TABLE 5. Reinterventions after primary operation
Nonsurvivors (n ¼ 42)
Reoperations and catheter reinterventions after single ventricle
palliation
Blalock–Taussig shunt revisions: 12 (11 after stage I and 1 after
PA/IVS)
Right ventricle to pulmonary artery conduit revisions: 2
Aortic arch revision: 2
Tricuspid valvuloplasty: 1
Pulmonary artery band revisions (loosening or tightening): 1
Reoperations after 2 ventricle repair
Residual ventricular septal defect: 5
Left ventricle to aortic baffle: 2
Left atrioventricular valve regurgitation: 2
Revision of aortic arch: 1
Other
Right atrial tear repair: 1
Right atrial reduction, Maze procedure: 1
Reexploration for bleeding (thoracotomy: 2)
Diaphragm plication: 4
Reexploration for bleeding: 5
Restriction of atrial septal defect: 1
Heart transplantation: 1
Catheter reinterventions
Pulmonary artery dilatation: 3
Aortic arch dilatation: 3
Survivors (n ¼ 9)
Blalock–Taussig shunt revision: 3
Residual ventricular septal defect closure: 2
Heart transplantation: 1
Catheter reinterventions
Aortic arch balloon dilatation: 3
Patients may have more than 1 reintervention or no reintervention. PA, Pulmonary
artery; IVS, interventricular septum.
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Surgery-1 scoring systems were developed to allow for risk-
adjusted mortality outcomes in children with congenital
heart disease undergoing surgical intervention.9,10
However, it did not address the efficacy of the repair or
palliation in congenital heart surgery.
In the multivariable analysis, lower technical scores and
use of ECMO were the 2 independent variables associated
with death. We will discuss the role of these predictors in
light of our research findings with the aim of improving out-
come of neonatal cardiac surgery.
Surgical Technical Performance
Among the nonsurvivors, only 30% had optimal repair,
15% had adequate repair, and 55% had inadequate repair.
Inadequate technical scores correlated statistically with
death, and optimal scores correlated with survival—84%
(optimal), 7% (adequate), and 9% (inadequate)
(P<.001)—suggesting a strong survival impact of techni-
cal performance during neonatal cardiac surgery. By adopt-
ing this technical score, several important factors are
revealed. Among the nonsurvivors after single ventricle pal-
liation, systemic pulmonary shunt–related obstruction or in-
creased pulmonary blood flow compared with systemic
blood flow (of which only 1 was a right ventricular to pul-
monary artery conduit) and aortic arch narrowing were
the most frequent problems requiring a reintervention or re-
operation, which did result in death. More specifically, in
the Norwood cohort, shunt reinterventions and aortic arch
re-reconstructions were the most frequent reoperations
among nonsurvivors. However, re-repair of residual ven-
tricular septal defects followed by re-repair ofTABLE 4. Comparison of postoperative characteristics for matched
neonatal cohorts
Nonsurvivor
(n ¼ 56)
Survivors
(n ¼ 56)
P
value
Highest postoperative lactate 9.0 (2.6-23.5) 6.0 (1.5-27.1) <.001
ECMO 40 (71) 7 (13) <.001
ECMO to support CPR 20 (36) 4 (7) <.001
Reoperation (including for
bleeding, missed diagnosis)
42 (75) 9 (16) <.001
ECMO, Extracorporeal membrane oxygenation; CPR, cardiopulmonary resuscita-
tion.
1122 The Journal of Thoracic and Cardiovascular Suratrioventricular valve regurgitation and aortic arch were
more common reinterventions in the biventricular repair
cohort.
In an autopsy study of death after the Norwood procedure
from Children’s Hospital Boston 15 years ago, Bartram and
colleagues11 identified the causes of death after 122 Nor-
wood procedures. They found the most common causes
were impairment of coronary perfusion (33 patients,
27%), excessive pulmonary blood flow (23 patients,
19%), obstruction of pulmonary arterial blood flow (21 pa-
tients, 17%), neoaortic obstruction (17 patients, 14%), and
right ventricular failure (16 patients, 13%). Among the
nonsurvivors, coronary obstruction was a far less common
problem in our matched population, yet aortic arch recon-
struction and pulmonary blood flow regulation were fre-
quently fatal problems identified by Bartram and
colleagues.11 We observed 2 patients who did not survive
the Norwood procedure and died after irreversible poor ven-
tricular function. Catheterization angiography confirmed no
coronary flow. The decision at that timewas not to reoperate
on these patients.gery c November 2012
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procedure identified by Bartram and colleagues11 are
largely correctable, we have made some surgical progress
over the last 3 decades since the original Norwood proce-
dure. Technical modifications, such as division of the di-
minutive ascending aorta with side-to-side or end-to-end
anastomosis to the pulmonary artery, with tubularization
of the aortic arch, seems to be reproducible and to avoid cor-
onary insufficiency after stage 1 operations. Other strategies
to avoid arch obstruction have been used, with some encour-
aging results. For instance, recurrent arch obstruction has
been countered by resection of the coarctation shelf, with
reapproximation of the aorta directly or using the interdig-
itation technique, and the Sano modification of the right
ventricle–pulmonary artery conduit seems to improve early
survival in a randomized trial.12 However, the fixed size of
the systemic or pulmonary shunt is limiting and could lead
to over- or under-circulation despite selective use of 3-mm
Blalock–Taussig shunt for infants weighing less than 3 kg.
Clearly, there is always room to reduce time for surgery
while aiming for optimal technical performance. We noted
increased bypass times for the nonsurvivors, yet the cross-
clamp times were nearly identical. A possible reason for
this may be the attempts at weaning from cardiopulmonary
bypass given the cardiac function and contractility.
Although the purpose of this study is to confirm prior an-
ecdotal evidence that surgical outcomes are heavily depen-
dent on technical results, we did not focus on the causes of
inadequate repair. The mechanism for technical errors is
still one that eludes us from time to time.13 In broad cate-
gories, causes of inadequate surgical repair can be classified
as follows: (1) the challenges related to the patient in gen-
eral and the specific anatomic lesion, that is, preoperative
planning; (2) surgical instrument failure, technical factors
(eg, suture size and breakage), excessive muscular resec-
tion, and the interface among these factors; and (3) operator
proficiency and ability to execute surgical repair or pallia-
tion with minimal errors or repetition of procedural compo-
nents involved.
Categories 1 and 2 are difficult to predict because they are
based on cognitive comprehension at the time of multidisci-
plinary discussions and imaging. Attempts at improving
preoperative knowledge of the lesion using tangible
3-dimensional models may be helpful.14 A safe culture in
the operating room by timely recognition and risk-averse
behavior is essential to minimize any further implications
or ramifications thereof.15,16 A supportive perioperative
team throughout from admission to discharge is key to
success in highly specialized environments. For category
3, there is a learning curve to undergo, and this spans an
undefined period of time along the career span of the
surgeon. However, experienced surgeons have witnessed
this in lesions such as the ventricular septal defect and
arterial switch operation, and through the process ofThe Journal of Thoracic and Carauditing and retraining, optimal surgical procedures were
achieved and maintained long term.17,18Extracorporeal Membrane Oxygenation After
Neonatal Cardiac Surgery
ECMO has achieved 40% to 60% survival to discharge
after congenital heart surgery when deployed in a timely
manner.19 More specifically, ECMO after stage I recon-
struction for hypoplastic left heart was lifesaving in ap-
proximately one third of infants who would otherwise
have died. However, previous research has shown that
re-repair for residual defects while on ECMO20 was asso-
ciated with poor outcomes. In a study from the Toronto
Hospital for Sick Children before 1994, 100% who could
not be weaned after cardiopulmonary bypass because of re-
sidual defects died while on ECMO. Among those who re-
quired postcardiotomy ECMO without residual defects,
33.3% died. The authors concluded that the presence of ir-
reparable residual defects was a contraindication to
ECMO. Although our study design was aimed at determin-
ing differences in predictor outcomes for matched survi-
vors and nonsurvivors, ECMO was commonly associated
with nonsurvivors who experienced suboptimal surgical re-
pair or palliation.
The combination of low birth weight, prematurity, and
congenital heart disease in the newborn is a challenge to
the medical care team. Conservative surgical wisdom might
suggest allowing these patients to grow by adding on
weight, and reaching beyond the 2.5-kg threshold might re-
duce the risk of multiorgan failure after cardiopulmonary
bypass.21,22 However, an earlier series from our own
experience6 showed that delayed repair carried higher mor-
tality and morbidity.
Our findings are consistent with a recent study by Lech-
ner and colleagues,22 which was based on 46 neonates with
low birth weight and showed that history of prematurity was
not associated with a higher mortality; however, the number
of patients was small.
We have maintained an aggressive approach to early sur-
gical repair and early imaging (echocardiography, magnetic
resonance imaging, and catheterization) for patients who
demonstrate what we consider unsatisfactory clinical prog-
ress after neonatal cardiac surgery. We recently showed that
intraoperative imaging can change surgical outcome intrao-
peratively in a series of complex congenital cardiac surgical
cases.23Limitations
Study limitations are primarily related to the retrospec-
tive study design analyzing a prospectively maintained da-
tabase. The current study did not assess other secondary
factors, such as process of care, structure, and context of
our institutional organization.diovascular Surgery c Volume 144, Number 5 1123
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available to match for each death, it was not feasible to
match for surgeon experience or to more than 1 matching
survivor. Among the nonsurvivors, 15 patients had optimal
technical repair but died of poor ventricular function for
unknown reasons, reemphasizing the importance of other
aspects of cardiopulmonary bypass and myocardial protec-
tion management during neonatal surgery.CONCLUSIONS
When compared with matched survivors, death after
neonatal cardiac surgery is associated with inadequate
surgical repair or palliation and use of ECMO. Further
work is needed to find ways to attain and maintain opti-
mal technical performance during all neonatal cardiac
procedures.
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